SpaceX Stock Has Gone Nowhere Since Its First Day of Trading

SpaceX shares closed at $152.71 on Friday, roughly 5% below their $160.95 IPO debut, as recurring insider lockup expirations and a still-demanding valuation restrain the stock despite rapid revenue growth. Q2 revenue rose 92% year over year to $7.8 billion and net loss narrowed to $541 million, but $18.4 billion of capex—$15.8 billion directed to AI—more than doubled quarterly revenue. About 3.1 billion additional shares are scheduled to become eligible for trading through December, while the company trades near 65x annualized sales; a Sept. 28 Starship orbital attempt is the next potential catalyst.

Analysis

SPCX is transitioning from scarcity-driven IPO ownership to a continuous-clearing market. That changes the marginal buyer: momentum and retail demand can support discrete launch/AI headlines, but institutions will require evidence that incremental AI capex earns returns rather than merely extending a financing runway. Until the post-earnings unlock window clears, rallies are likely sold by holders with low cost bases, creating a mechanical ceiling independent of operating momentum.

The central valuation issue is not near-term profitability but capital intensity. If AI infrastructure spending remains materially above revenue, the market will begin valuing SPCX on forward external-financing needs and eventual returns on invested capital, rather than revenue growth; that is a multiple-compression risk even if sales continue to surprise upward. A successful Starship event can improve the long-duration satellite-launch narrative, but it does little to validate the much larger AI investment case unless management pairs it with utilization, backlog conversion, and gross-margin disclosures.

NVDA and the broader AI hardware complex have a conditional positive read-through: sustained deployment by a well-capitalized buyer supports demand visibility, but a SPCX capex reset would be an early warning that private/IPO-funded AI buildouts are less durable than hyperscaler spending. The contrarian setup is that a benign December unlock could be bullish precisely because it removes the technical overhang; however, that outcome matters only if third-quarter bookings convert to revenue without another step-up in cash burn.

Key Decisions for Investors

• Maintain no outright long in SPCX before the late-October/December liquidity events; reassess 5-10 trading days after the largest release using price/volume absorption and reported insider-sales data. A close above the post-IPO high on above-average volume after the release would falsify the near-term supply-overhang thesis.
• For tactical exposure, favor a defined-risk SPCX put spread dated after the third-quarter report and December release rather than naked short stock: target strikes centered around a 15-25% downside window from entry. Thesis works if unlock-related supply and capex concerns re-rate the multiple; exit if management shows improving AI gross margin, capex-to-revenue moderation, and the shares absorb releases without widening volatility.
• Use a relative-value watch: long NVDA versus short SPCX only after a failed SPCX rally into an unlock date, sized beta-neutral. The trade isolates mature, externally validated AI demand from a capital-intensive, unproven monetization model; cover if SPCX discloses backlog-to-revenue conversion and cash-flow metrics that support a credible AI return profile.
• Do not treat launch success as a standalone long catalyst. Upgrade only if subsequent guidance demonstrates monetizable launch cadence or satellite economics, while AI capex remains funded without materially worsening free-cash-flow burn over the next 1-3 quarters.